Divya Iyer is the Senior Vice President, Head of Revenue, Pharma Direct at GoodRx, where she oversees the teams responsible for building, scaling, and sustaining pharmaceutical manufacturer partnerships that help patients access their medications more affordably and with less friction. Prior to this role, Divya served as Senior Vice President, Go-To-Market Strategy, where she helped shape GoodRx’s approach to pharmaceutical partnerships and strengthen its position as a trusted commercialization partner for manufacturers. Under Divya’s leadership, GoodRx has collaborated with major pharmaceutical companies to improve patient access, including by introducing some of the lowest available self-pay prices for widely used therapies, while driving meaningful increases in filled prescriptions. Previously, Divya held senior roles at McKesson, where she transformed the company’s biopharma strategy and launched a new oncology data and insights business. She also served as a management consultant at Deloitte, advising pharmaceutical clients on corporate and commercial strategy, and began her career at Merck in clinical development. Divya holds degrees in Pharmacy and Neuropharmacology, as well as an MBA from NYU Stern. She has been recognized by MM+M “40 Under 40”, PM360 “ELITE 100”, and as a Luminary by the Healthcare Businesswomen’s Association.